Bio-lysozyme Plus Nystatin Thrush Treatment of Clinical Observation of Infants and Young Children
Kaizheng Chen
Abstract
Kaizheng Chen
Abstract
Objective:To explore the biological lysozyme plus nystatin treatment efficacy of thrush in infants.Methods:60 cases included children with thrush were randomly divided into two groups,treatment group 30 cases,30 cases of the control group.Treatment group,bio-lysozyme plus nystatin treatment,the control group,but treatment with nystatin.Results:The clinical efficacy and control groups were 100% and 86.7%,the difference was statistically significant(P0.05).Conclusions:The application of biotechnology lysozyme plus nystatin treatment of infantile thrush its clinical efficacy accurate,safe and easy,suitable for popularization and application of primary hospital.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the biological lysozyme plus nystatin treatment efficacy of thrush in infants.Methods:60 cases included children with thrush were randomly divided into two groups,treatment group 30 cases,30 cases of the control group.Treatment group,bio-lysozyme plus nystatin treatment,the control group,but treatment with nystatin.Results:The clinical efficacy and control groups were 100% and 86.7%,the difference was statistically significant(P0.05).Conclusions:The application of biotechnology lysozyme plus nystatin treatment of infantile thrush its clinical efficacy accurate,safe and easy,suitable for popularization and application of primary hospital.
Key concepts: Nystatin, Thrush, Lysozyme, Medicine, Clinical efficacy, Significant difference, Treatment and control groups, Internal medicine